Because Notch1 expression is pivotal for the pathogenesis of T-ALL, TP53 or c-myc were knocked down using siRNA whereas BLM was treated as DNA damaging agent to examine the relationship among DNA damage, the alternative splicing of FIR, and cell cycle control. This evidence concerns the gene BLM and acute lymphoblastic leukemia.